StockData
Chemours Co logo

Chemours Co (CC) stock

CCNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$12.18−0.30 (-2.40%)

Close on Nov 17, 2026Market cap $1.83BP/E –Yield 4.21%

Chemours revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Chemours's revenue for the twelve months ending Jun 30, 2026 was $5.80B, down 0.9% year over year. For fiscal 2025 it was $5.81B, up 0.4% from the year before. Over ten years it grew 0.2% a year on average. The highest annual figure on record is $6.86B in fiscal 2013.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.81B+0.4%
FY2024Dec 31, 2024$5.78B-4.9%
FY2023Dec 31, 2023$6.08B-11.0%
FY2022Dec 31, 2022$6.83B+7.7%
FY2021Dec 31, 2021$6.35B+27.7%
FY2020Dec 31, 2020$4.97B-10.1%
FY2019Dec 31, 2019$5.53B-16.8%
FY2018Dec 31, 2018$6.64B+7.4%
FY2017Dec 31, 2017$6.18B+14.5%
FY2016Dec 31, 2016$5.40B-5.5%
FY2015Dec 31, 2015$5.72B-11.1%
FY2014Dec 31, 2014$6.43B-6.2%
FY2013Dec 31, 2013$6.86B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.59B-1.5%
Q1 FY2026Mar 31, 2026$1.38B+1.0%
Q4 FY2025Dec 31, 2025$1.33B-2.2%
Q3 FY2025Sep 30, 2025$1.50B-0.9%
Q2 FY2025Jun 30, 2025$1.62B+3.9%
Q1 FY2025Mar 31, 2025$1.37B+0.4%
Q4 FY2024Dec 31, 2024$1.36B-0.7%
Q3 FY2024Sep 30, 2024$1.51B+0.5%
Q2 FY2024Jun 30, 2024$1.55B-6.4%
Q1 FY2024Mar 31, 2024$1.36B-12.1%
Q4 FY2023Dec 31, 2023$1.37B+2.2%
Q3 FY2023Sep 30, 2023$1.50B-15.5%
Q2 FY2023Jun 30, 2023$1.66B-13.3%
Q1 FY2023Mar 31, 2023$1.55B-12.2%
Q4 FY2022Dec 31, 2022$1.34B-15.0%
Q3 FY2022Sep 30, 2022$1.78B+5.8%
Q2 FY2022Jun 30, 2022$1.92B+15.7%
Q1 FY2022Mar 31, 2022$1.76B+22.8%
Q4 FY2021Dec 31, 2021$1.58B+17.7%
Q3 FY2021Sep 30, 2021$1.68B+36.3%
Q2 FY2021Jun 30, 2021$1.66B+51.4%
Q1 FY2021Mar 31, 2021$1.44B+10.0%
Q4 FY2020Dec 31, 2020$1.34B-1.1%
Q3 FY2020Sep 30, 2020$1.23B-11.3%
Q2 FY2020Jun 30, 2020$1.09B-22.4%
Q1 FY2020Mar 31, 2020$1.31B-5.2%
Q4 FY2019Dec 31, 2019$1.35B-7.6%
Q3 FY2019Sep 30, 2019$1.39B-14.6%
Q2 FY2019Jun 30, 2019$1.41B-22.5%
Q1 FY2019Mar 31, 2019$1.38B-20.5%
Q4 FY2018Dec 31, 2018$1.46B-7.0%
Q3 FY2018Sep 30, 2018$1.63B+2.8%
Q2 FY2018Jun 30, 2018$1.82B+14.4%
Q1 FY2018Mar 31, 2018$1.73B+20.4%
Q4 FY2017Dec 31, 2017$1.58B+19.1%
Q3 FY2017Sep 30, 2017$1.58B+13.3%
Q2 FY2017Jun 30, 2017$1.59B–
Q1 FY2017Mar 31, 2017$1.44B–
Q4 FY2016Dec 31, 2016$1.32B–
Q3 FY2016Sep 30, 2016$1.40B–

More Chemours figures

See a number that looks wrong?